Bleeding News and Research

RSS

Study: Caplacizumab not cost effective for treating thrombotic thrombocytopenic purpura

In a new study by Yale Cancer Center researchers, the drug caplacizumab is shown not to be cost-effective in treating thrombotic thrombocytopenic purpura (TTP) when added to the standard-of-care.

7 Dec 2020

Los Robles enrolls first patient in landmark trial for treatment of chronic subdural hematoma

Los Robles Health System is leading the way in neurovascular clinical trials enrolling the first patient in the nation in STEM, the Squid trial for the treatment of chronic subdural hematoma (cSDH).

5 Dec 2020

Aprotinin inhibits SARS-CoV-2 entry and replication in cells cultures

Researchers at the University of Kent in the UK and the Hannover Medical School and Goethe University in Germany have observed that the protease inhibitor aprotinin can inhibit viral replication by preventing SARS-CoV-2 entry into host cells.

24 Nov 2020

Picosun’s Medical ALD Solutions Enable Safer Surgeries

ESPOO, Finland, 23rd November 2020 – Picosun Group, the leading supplier of AGILE ALD® (Atomic Layer Deposition) thin-film coating solutions, partners with prominent Chinese hospitals and researchers to apply medical ALD technology for safer surgical procedures.

23 Nov 2020

Researchers propose to make new laser 'blade' for medical scalpels

Scientists from Tomsk Polytechnic University and Saratov State University teamed up with colleagues from Taiwan and proposed to make a laser 'blade' for a medical scalpel with a specified curved shape using a photonic 'hook'.

22 Nov 2020

NIH-funded study to test emergency treatment for devastating stroke in Memphis

The University of Tennessee Health Science Center's Stroke Team is joining researchers from more than 100 hospitals worldwide to conduct a National Institutes of Health (NIH)-funded research study called FASTEST that will test the safety and efficacy of a medication called recombinant factor Vlla to prevent hemorrhage expansion in patients with strokes caused by bleeding in the brain - intracerebral hemorrhage strokes.

19 Nov 2020

COVID-19's harmful neurological effects are more common in patients with hypertension, diabetes

Some patients with COVID-19 are at higher risk of neurological complications like bleeding in the brain and stroke, according to a study being presented at the annual meeting of the Radiological Society of North America.

18 Nov 2020

Diabetes and hypertension may increase the risk of COVID-19 brain complications

New data has revealed those with type 2 diabetes and hypertension are at an increased risk of neurological complications following infection with COVID-19.

18 Nov 2020

Short, one-month dual anti-platelet treatment is safe and effective after stent placement

A one-month treatment of dual anti-platelet therapy is safe and as effective as a longer duration of therapy at preventing cardiac events in patients one year after stent placement, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.

16 Nov 2020

Potent antiplatelet drug not superior to standard of care in reducing heart attack risk during angioplasty

The use of the more potent antiplatelet medication ticagrelor was not superior to clopidogrel in the reduction of the rate of heart attack or severe complications among people undergoing an elective procedure to open a blocked artery, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.

16 Nov 2020

Study could pave the way for potential urine test to diagnose liver fibrosis

Fifty fragments of proteins, termed peptides, have been identified in the urine of liver fibrosis patients in a new study that could pave the way for a potential diagnostic urine test for the condition if further validated.

16 Nov 2020

Endothelial cells resistant to SARS-CoV-2 infection

A team of scientists from Imperial College London has conducted a series of in vitro studies to investigate the susceptibility of endothelial cells to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, the causative pathogen of coronavirus disease 2019 (COVID-19).

10 Nov 2020

Aspirin to be tested as a potential COVID-19 treatment as part of RECOVERY trial

Now, in new research, the everyday painkiller aspirin will be evaluated as a potential treatment for COVID-19 in one of the United Kingdom’s most significant trials, aiming to evaluate whether it can reduce the risk of blood clots in infected people.

9 Nov 2020

Centhaquine drug improves outcomes, reduces death rate in patients with severe blood or fluid loss

Centhaquine, a new medication to treat patients who have severe blood or fluid loss, significantly improved outcomes and reduced death rate when added to standard of care, compared to standard care alone, according to preliminary research to be presented at the American Heart Association's Resuscitation Science Symposium 2020.

9 Nov 2020

Bleeding News and Research

Study: Caplacizumab not cost effective for treating thrombotic thrombocytopenic purpura

Los Robles enrolls first patient in landmark trial for treatment of chronic subdural hematoma

Aprotinin inhibits SARS-CoV-2 entry and replication in cells cultures

Picosun’s Medical ALD Solutions Enable Safer Surgeries

Researchers propose to make new laser 'blade' for medical scalpels

NIH-funded study to test emergency treatment for devastating stroke in Memphis

COVID-19's harmful neurological effects are more common in patients with hypertension, diabetes

Diabetes and hypertension may increase the risk of COVID-19 brain complications

Short, one-month dual anti-platelet treatment is safe and effective after stent placement

Potent antiplatelet drug not superior to standard of care in reducing heart attack risk during angioplasty

Study could pave the way for potential urine test to diagnose liver fibrosis

Endothelial cells resistant to SARS-CoV-2 infection

Aspirin to be tested as a potential COVID-19 treatment as part of RECOVERY trial

Centhaquine drug improves outcomes, reduces death rate in patients with severe blood or fluid loss

Persistent and extensive lung damage seen in COVID-19 patients

Multidisciplinary curriculum helps surgical residents to better treat victims of firearm violence

Children with minor perinatal brain bleeds have normal cognitive development at two years of age

Research projects receive BTCA grants to develop novel drugs for various diseases

Simple diagnostic can help deliver urgent treatment to people at risk of dying from rapid blood loss

Severe ulcerative colitis linked to a newly-discovered strain of oral bacteria

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News